CHEMFAB ALKALIS LIMITED: Audited Financial Results for Q4FY26 & Dividend Recommendation
Chemfab Alkalis Limited reported audited results for Q4FY26. Standalone net profit after tax was ₹50.228 lakhs, and consolidated net profit was ₹185.77 lakhs. For the full year, standalone net profit was ₹2009.21 lakhs, and consolidated net profit was ₹4846 lakhs. The Board recommended a final dividend of ₹1.25 per share.
The financial results are positive, and the dividend recommendation is a good sign for shareholders. However, the impact is moderate as there are no extraordinary growth figures or significant strategic announcements.
The company reported positive financial results with an increase in profit and recommended a final dividend, which is generally viewed positively by investors.
Chemfab Alkalis Limited has announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The company published these results in the Business Standard (English) and Makkal Kural (Tamil) newspapers on May 15, 2026, in compliance with SEBI LODR Regulations, 2015.
The audited financial results for the quarter ended March 31, 2026, show a Total Income from Operations of ₹26.42 lakhs (standalone) and ₹6,872.61 lakhs (consolidated). Net profit for the period after tax stood at ₹50.228 lakhs (standalone) and ₹185.77 lakhs (consolidated).
For the year ended March 31, 2026, the Total Income from Operations was ₹3612.36 lakhs (standalone) and ₹74775.7 lakhs (consolidated). The Net Profit for the year after tax was ₹2009.21 lakhs (standalone) and ₹4846 lakhs (consolidated).
Additionally, the Board of Directors has recommended a final dividend of ₹1.25 per equity share for the financial year 2025-26, subject to shareholder approval at the upcoming Annual General Meeting.
What to do with a filing like this
Chemfab Alkalis Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Chemfab Alkalis Limited. Read the original for the full detail.